Literature DB >> 8631818

A disulfide-bonded dimer of the Golgi beta-galactoside alpha2,6-sialyltransferase is catalytically inactive yet still retains the ability to bind galactose.

J Ma1, K J Colley.   

Abstract

The alpha2,6-sialyltransferase is a terminal glycosyltransferase localized in the trans Golgi and trans Golgi network. Here we show that 30% of the total rat liver Golgi alpha2,6-sialyltransferase forms a disulfide-bonded 100-kDa species that can be converted to the 50-kDa monomer form of the enzyme upon reduction. Limited proteolysis of both enzyme forms demonstrates that the 100-kDa species is a disulfide-bonded homodimer of the alpha2,6-sialyltransferase. The alpha2,6-sialyltransferase disulfide-bonded dimer is found in bovine liver Golgi membranes and in Golgi membranes prepared and solubilized in the presence of 100 mM iodoacetamide, suggesting that it is not unique to rat liver or formed aberrantly upon membrane lysis. The dimer form of the enzyme possesses no significant catalytic activity and has a much lower affinity for CDP-hexanolamine-agarose compared with the monomer form. In contrast, both the alpha2,6-sialyltransferase monomer and the disulfide-bonded dimer bind strongly to galactose and galactose-terminated substrates. These results suggest that the alpha2,6-sialyltransferase disulfide-bonded dimer lacks catalytic activity due to a weak affinity for its sugar nucleotide donor, CMP-NeuAc, and that this catalytically inactive form of the enzyme may act as a galactose-specific lectin in the Golgi.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8631818     DOI: 10.1074/jbc.271.13.7758

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  16 in total

1.  A ganglioside-specific sialyltransferase localizes to axons and non-Golgi structures in neurons.

Authors:  C A Stern; M Tiemeyer
Journal:  J Neurosci       Date:  2001-03-01       Impact factor: 6.167

2.  Localization of alpha 1,3-fucosyltransferase VI in Weibel-Palade bodies of human endothelial cells.

Authors:  S Schnyder-Candrian; L Borsig; R Moser; E G Berger
Journal:  Proc Natl Acad Sci U S A       Date:  2000-07-18       Impact factor: 11.205

Review 3.  Organization of Golgi glycosyltransferases in membranes: complexity via complexes.

Authors:  W W Young
Journal:  J Membr Biol       Date:  2004-03-01       Impact factor: 1.843

4.  The transmembrane domain of the severe acute respiratory syndrome coronavirus ORF7b protein is necessary and sufficient for its retention in the Golgi complex.

Authors:  Scott R Schaecher; Michael S Diamond; Andrew Pekosz
Journal:  J Virol       Date:  2008-07-16       Impact factor: 5.103

5.  Proteolytic shedding of ST6Gal-I by BACE1 regulates the glycosylation and function of alpha4beta1 integrins.

Authors:  Alencia V Woodard-Grice; Alexis C McBrayer; John K Wakefield; Ya Zhuo; Susan L Bellis
Journal:  J Biol Chem       Date:  2008-07-23       Impact factor: 5.157

Review 6.  The role of glycoproteins in neural development function, and disease.

Authors:  K C Breen; C M Coughlan; F D Hayes
Journal:  Mol Neurobiol       Date:  1998-04       Impact factor: 5.590

7.  Reconstitution of glucosylceramide flip-flop across endoplasmic reticulum: implications for mechanism of glycosphingolipid biosynthesis.

Authors:  Madhavan Chalat; Indu Menon; Zeynep Turan; Anant K Menon
Journal:  J Biol Chem       Date:  2012-03-15       Impact factor: 5.157

Review 8.  IgG and leukocytes: Targets of immunomodulatory α2,6 sialic acids.

Authors:  Mark B Jones
Journal:  Cell Immunol       Date:  2018-03-31       Impact factor: 4.868

9.  Golgi N-glycosyltransferases form both homo- and heterodimeric enzyme complexes in live cells.

Authors:  Antti Hassinen; Antti Rivinoja; Annika Kauppila; Sakari Kellokumpu
Journal:  J Biol Chem       Date:  2010-04-08       Impact factor: 5.157

10.  Human xylosyltransferase I: functional and biochemical characterization of cysteine residues required for enzymic activity.

Authors:  Sandra Müller; Manuela Schöttler; Sylvia Schön; Christian Prante; Thomas Brinkmann; Joachim Kuhn; Christian Götting; Knut Kleesiek
Journal:  Biochem J       Date:  2005-03-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.